Medical dermatology leader eliminates data silos and gains real-time oversight

医学皮肤病学领导者消除了数据仓库并获得了实时监督

PLEASANTON, Calif., Oct. 3, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that LEO Pharma, a global leader in medical dermatology, is using Veeva Vault Safety to optimize its safety operations. With this foundation, the company can seamlessly incorporate affiliates into safety workflows, boost operational efficiencies, ensure compliance, and unify its global pharmacovigilance data on one platform..

加利福尼亚州普莱森顿，2023年10月3日/PRNewswire/-Veeva Systems（纽约州：VEEV）今天宣布，医学皮肤病学全球领导者LEO Pharma正在使用Veeva穹窿安全性来优化其安全操作。在此基础上，公司可以将附属公司无缝纳入安全工作流程，提高运营效率，确保合规性，并在一个平台上统一其全球药物警戒数据。。

'LEO Pharma is deeply committed to the safety of patients using its products,' said Pilar Carrero, vice president of global safety at LEO Pharma. 'With Veeva Vault Safety, we now have real-time visibility into adverse events and data transparency for affiliates that helps us work even better together.'.

利奥制药公司全球安全副总裁Pilar Carrero说：“利奥制药公司坚信致力于患者使用其产品的安全。”通过Veeva穹顶安全，我们现在可以实时了解附属公司的不良事件和数据透明度，帮助我们更好地合作。

Vault Safety is helping LEO Pharma improve oversight of case intake, processing, submission, and distribution while simplifying safety workflows and eliminating data reconciliation with affiliates and partners. By standardizing drug development on Veeva Development Cloud, LEO Pharma can better connect safety to other crucial business areas like clinical, regulatory, and quality..

穹窿安全正在帮助LEO Pharma改善对案例摄入，处理，提交和分发的监督，同时简化安全工作流程并消除与附属公司和合作伙伴的数据核对。通过在Veeva开发云上标准化药物开发，LEO Pharma可以更好地将安全性与临床，监管和质量等其他关键业务领域联系起来。。

'Now, all parties have visibility into case data, ownership, and status, facilitating improved collaboration and sharing of learnings,' said John Lawrie, vice president of Vault Safety at Veeva. 'Veeva is happy to partner with LEO Pharma to make its safety operations simpler and more effective.'

“现在，所有各方都可以了解案例数据，所有权和地位，促进改进合作和分享学习，”Veeva拱顶安全副总裁John Lawrie说Veeva很高兴与LEO Pharma合作，使其安全操作更简单，更有效

Vault Safety is a safety case management system that enables end-to-end adverse event intake, processing, and submission for clinical and marketed products. It is part of Veeva Development Cloud, the technology foundation for drug development that brings together clinical, regulatory, safety, and quality applications to drive end-to-end business processes..

拱顶安全是一种安全案例管理系统，可以为临床和市场产品提供端到端的不良事件摄入，处理和提交。它是Veeva Development Cloud的一部分，Veeva Development Cloud是药物开发的技术基础，汇集了临床，监管，安全和质量应用程序，以推动端到端的业务流程。。

Additional Information For more on Veeva Vault Safety, visit: veeva.com/VaultSafety Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems

有关Veeva穹窿安全性的更多信息，请访问：Veeva.com/aurcultsafety在LinkedIn上与Veeva连接：LinkedIn.com/company/Veeva-systems

About Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.

关于Veeva SystemsVeeva是生命科学行业云软件的全球领导者。致力于创新，卓越产品和客户成功，Veeva为1000多名客户提供服务，从世界上最大的生物制药公司到新兴生物技术公司。作为一家公益公司，Veeva致力于平衡所有利益相关者的利益，包括客户，员工，股东及其所服务的行业。

For more information, visit veeva.com..

欲了解更多信息，请访问veeva.com。。

Veeva Forward-looking StatementsThis release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements.

Veeva前瞻性声明本版本包含有关Veeva产品和服务的前瞻性声明以及使用我们的产品和服务的预期结果或收益。这些陈述基于我们目前的期望。实际结果可能与本版本中提供的结果有很大不同，我们没有义务更新此类声明。

There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2023, which you can find here (a summary of risks which may impact our business can be found on pages 38 and 39), and in our subsequent SEC filings, which you can access at sec.gov..

有许多风险可能对我们的结果产生负面影响，包括我们在2023年7月31日结束的期间提交的表格10-Q中披露的风险和不确定性，您可以在此处找到（风险摘要可能会影响我们的业务可以在第38页和第39页找到），以及我们随后的SEC申请中，您可以在SEC.gov访问。。

Contact:

联系方式：

Jeremy WhittakerVeeva Systems+49-695-095-5486[email protected]

Jeremy WhittakerVeeva Systems+49-695-095-5486[电子邮件保护]

Deivis MercadoVeeva Systems925-226-8821[email protected]

Deivis MercadoVeeva Systems925-226-8821[电子邮件保护]

SOURCE Veeva Systems

源Veeva系统